Low dose oral alpha-interferon therapy for patients seropositive for human immunodeficiency virus type-1 (HIV-1).
View/ Open
Date
1990-06Author
Koech, DK
Obel, AO
Minowada, J
Hutchinson, VA
Cummins, JM
Type
ArticleLanguage
enMetadata
Show full item recordAbstract
Thirty eight symptomatic and two asymptomatic patients seropositive for human immunodeficiency virus type-1 (HIV-1) were treated with a natural human interferon alpha (HuIFN alpha). Patients were given 2 IU/kg HuIFN alpha orally once daily in powdered maltose held in the mouth to promote mucosal absorption. This oral immunomodulating HuIFN alpha therapy resulted in an increase in CD4+ lymphocytes, an increase in weight, and a dramatic alleviation of clinical symptoms related to HIV-1 infection.
URI
http://www.ncbi.nlm.nih.gov/pubmed/1973045http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/37345
Citation
Mol Biother. 1990 Jun;2(2):91-5.Publisher
University of Nairobi College of Health Sciences,University of Nairobi
Collections
- Faculty of Health Sciences (FHS) [10387]